AzTrials
AzTrials

Experts in Physical Activity Prescription and Risk Health ScreeningAPPA e-DelphiNCT07475221

Expert Validation of an Autonomous Personalized Physical Activity Algorithm

An observational study of Experts in Physical Activity Prescription and Risk Health Screening, run by Polytechnic Institute of Porto at 1 site in Portugal.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study aims to validate a personalized physical activity algorithm for risk screening and individualized exercise prescription using a modified online Delphi process. International experts in physical activity and exercise will evaluate the algorithm's components over two rounds of questionnaires, with consensus… Read more about this study

Who is it for?
Ages 18 years and older
How many people
9 participants
Where
1 sitePortugal
Study dates
10 Mar 2026to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population will consist of international experts in the field of Physical Activity and Exercise. Participants will be identified based on their recognized scientific or professional experience and possession of a relevant doctoral degree. Recruitment will be primarily via institutional email invitations, supplemented by personal contacts when needed. Eligible experts will voluntarily participate in two rounds of an online modified Delphi questionnaire and, if required, an online focus group to resolve any remaining disagreements. The targeted panel size is 9 - 18 experts to ensure representativeness and methodological robustness.

Who may be able to join

  • Experts in Physical Activity and Exercise with recognized scientific or professional experience and a relevant doctoral degree.
  • Availability to complete two rounds of the online modified Delphi questionnaire.
  • Willingness to participate in an online focus group if consensus is not reached.
  • Ability and willingness to provide informed consent.

Who cannot join

  • Individuals unable to provide informed consent.
  • Individuals without access to a computer, smartphone, tablet, or other internet-enabled device necessary to complete the online survey.

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • School of Health - Polytechnic Institute of Porto

    Porto, 4200-072

Other trials in Portugal

About this study

Official title: Validation of a Personalized Physical Activity Algorithm Via Modified e-Delphi (InnovaMotion Project)

This study aims to validate a personalized physical activity algorithm for risk screening and individualized exercise prescription using a modified online Delphi process. International experts in physical activity and exercise will evaluate the algorithm's components over two rounds of questionnaires, with consensus defined as ≥70% agreement. If needed, a focus group will resolve any remaining disagreements. Validation of this algorithm may support safer, more effective autonomous exercise, promoting adherence, improved health outcomes, and population-level benefits.

Read the detailed description

Study Phases - eDelphi Validation of the APPA Algorithm

Phase 1 - Round 1 (Initial Online Questionnaire):

The first phase consists of an online survey in which international experts in physical activity and exercise will evaluate the components of the personalized physical activity algorithm for health risk screening and individualized exercise prescription. Experts will assess the relevance, clarity, and clinical appropriateness of each item. Feedback from this round will identify items requiring modification or clarification.

Phase 2 - Round 2 (Re-evaluation):

The second phase consists of a consecutive online survey round, in which experts will re-evaluate the revised algorithm components based on feedback from Round 1. Experts will have the opportunity to adjust their ratings. This phase aims to move items closer to consensus (≥70% agreement).

Phase 3 - Optional Focus Group (if needed):

If consensus is not reached on specific items after Round 2, an online focus group will be conducted to discuss and resolve remaining disagreements. This discussion will help refine the algorithm and ensure agreement on all components.

Keywords
eDelphi, physical activity, Modified Delphi, Digital Health, Expert Consensus, Exercise Prescription, screening, health risk stratification
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07475221
Study groupRoleWhat they receive
Expert PanelCohort of experts in physical activity and exercise with recognized scientific or professional experience and a relevant doctoral degree. Experts will validate a digital algorithm for health risk screening and individualized physical activity prescription via a modified online Delphi process. Two rounds of anonymous questionnaires will assess the relevance, clarity, and clinical appropriateness of algorithm components. If consensus (≥70% agreement) is not reached, a follow-up online focus group will resolve disagreements. Recruitment will be through institutional emails and professional networks. Participation is voluntary, with informed consent obtained. Panel size: 9-18 experts, consistent with Delphi methodology to ensure representativeness and robustness.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Expert consensus on algorithm components

    Consensus defined as ≥70% agreement among experts using a 9-point Likert scale in a two-round modified Delphi process evaluating the relevance and clarity of algorithm items.

    Measured: Up to 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2026
  2. Study start10 Mar 2026
  3. Primary completion30 Jun 2026
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
9 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07475221
Sponsor's protocol ID
CE0073F
Other IDs
02/C06-i03.03/2021.PID-15, UID/05210/2025
Acronym
APPA e-Delphi
Status last verified
Mar 2026
First submitted
12 Mar 2026
Last updated
25 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Experts in Physical Activity Prescription and Risk Health Screening, run by Polytechnic Institute of Porto at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 25 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Expert consensus on algorithm components (time frame: Up to 2 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in